Warning letter
Diagnostic Imaging Associates: warning letter of Feb 29, 2000
FDA warning letter UCM068171 · New York District Office
Key facts
| Reference number | UCM068171 |
|---|---|
| Company | Diagnostic Imaging Associates |
| Subject | Mammography Standards |
| Issue date | Feb 29, 2000 |
| Posted date | Feb 29, 2000 |
| Issuing office | New York District Office |
| Product type | Devices |
| Country | 3 |
| Inspection city | Brooklyn |
| Inspection ZIP | 11229-4507 |
| Inspection start date | Feb 22, 2000 |
| Letter on fda.gov | web.archive.org |
At a glance
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: